IFNG and tuberculosis: The above data suggest that PD-1/PD-L1 blockade can increase Mtb-specific IFN-γ production in both groups of individuals with LTBI and active TB, but does not augment Mtb-specific T cell proliferative capacity in smear+ TB patients.